Neuronal injury and neuroprotection

被引:3
|
作者
Menon, David K. [1 ,2 ]
Wheeler, Daniel W. [1 ]
机构
[1] Univ Cambridge, Anaesthesia, Cambridge, England
[2] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England
来源
关键词
agents; brain; hypoxia; injury; ischaemia; neuroprotective; neurosurgery; stroke; trauma;
D O I
10.1383/anes.6.6.184.65786
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Cerebral ischaemia is responsible for many deaths and causes an enormous amount of disability. Neurons are particularly susceptible to ischaemic injury because of their high metabolic rate and associated oxygen and energy requirements, and because brain repair mechanisms in humans appear to be absent or very limited. Primary neuronal injury may result from focal or global ischaemia, or traumatic brain injury. After injury, chains of physiological and pathophysiological events occur (e.g. inflammation) that cause secondary brain injury. This article describes these processes, and the efforts that have been made to intervene to improve outcome after cerebral ischaemia. Although the benefit of optimizing oxygenation and controlling intracranial pressure are beyond doubt, many potentially neuroprotective compounds that have been studied have been unsuccessful, despite promising results in experimental animal models. The authors discuss the reasons why this may be, and the growing realization that not all the processes previously thought to cause secondary injury are deleterious after all, and that a subtle interplay between them may offer some degree of neuroprotection or even brain repair. © 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:184 / 188
页数:5
相关论文
共 50 条
  • [41] Neuroprotection of microglia-conditioned medium (MCM) on excitotoxic neuronal injury through inhibition of large cation conductance
    Hayashi, Yoshiori
    Fujita, Setsuko
    Odagaki, Yoshihiko
    Shinagawa, Rika
    Kagamiishi, Yoshihumi
    Nakanishi, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 104P - 104P
  • [42] Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury
    Cho Y.
    Shi R.
    Ben Borgens R.
    Journal of Biological Engineering, 4 (1)
  • [43] Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection
    Zoerle, Tommaso
    Carbonara, Marco
    Zanier, Elisa R.
    Ortolano, Fabrizio
    Bertani, Giulio
    Magnoni, Sandra
    Stocchetti, Nino
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [44] Resilience to Injury: A New Approach to Neuroprotection?
    Neel S. Singhal
    Chung-Huan Sun
    Evan M. Lee
    Dengke K. Ma
    Neurotherapeutics, 2020, 17 : 457 - 474
  • [45] Resilience to Injury: A New Approach to Neuroprotection?
    Singhal, Neel S.
    Sun, Chung-Huan
    Lee, Evan M.
    Ma, Dengke K.
    NEUROTHERAPEUTICS, 2020, 17 (02) : 457 - 474
  • [46] Neuroprotection by Docosahexaenoic Acid in Brain Injury
    Kim, Hee-Yong
    MILITARY MEDICINE, 2014, 179 (11) : 106 - 111
  • [47] Neuroprotection Trials in Traumatic Brain Injury
    Chakraborty, Shamik
    Skolnick, Brett
    Narayan, Raj K.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04) : 1 - 8
  • [48] Neuroprotection for Ischemic Injury in the Immature Brain
    Comi, Anne M.
    CURRENT PEDIATRIC REVIEWS, 2005, 1 (02) : 135 - 145
  • [49] Inflammation and Neuroprotection in Traumatic Brain Injury
    Corps, Kara N.
    Roth, Theodore L.
    McGavern, Dorian B.
    JAMA NEUROLOGY, 2015, 72 (03) : 355 - 362
  • [50] THE NEUROPROTECTION THERAPY OF THE TRAUMATIC BRAIN INJURY
    Krasnenkova, M.
    Sabirov, D.
    ANESTHESIA AND ANALGESIA, 2016, 123 : 214 - 214